Abiopharma

DAT: Spot truckload rates rise in May on capacity pressure across the market

Eva Live Establishes Eva Defense Inc. to Pursue Acquisitions in the Rapidly Expanding Drone and Defense Technology Market

Enveric Biosciences Announces Participation in 2026 BIO International Convention

VIA INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Via Transportation, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Korn Ferry to Report Quarterly Earnings via Live Webcast on June 23, 2026

Nexalin Technology Announces Two Clinical Abstracts Accepted for Presentation at the 2026 NYC Neuromodulation Conference Highlighting Preliminary Clinical Results Across Anxiety, Depression, Insomnia and Quality of Life

Clinical trial NCT04464759 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2027-01-06 → 2027-05-12 3. primary completion date: 2027-01-06 → 2026-07-31 4. enrollment: 94 → 41 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07502417 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 16 → 15 participants 3. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT05617885: status: ACTIVE_NOT_RECRUITING → COMPLETED.

Clinical trial NCT07566338 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-05-01 → 2026-05-06